Ro CEO shares the making of its new AI agent
Over 9 years, Zach Reitano has evolved Ro as patient needs and healthcare have changed, from early direct-to-patient services to GLP-1 care.
Over nine years, Zach Reitano has repeatedly evolved Ro as patient needs and the healthcare market have changed, from its early direct-to-patient services to a leading platform for GLP-1 care.
During Business Insider's The Long Play, Reitano discussed the business decisions behind those shifts and how the company is positioning itself for the next era of consumer health.
As part of his conversation with Business Insider legal correspondent Melia Robinson, he also shared what he's learned as a founder leading in an era of quick and unrelenting change.
Read the original article on Business Insider